首页 > 最新文献

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia最新文献

英文 中文
Prognostic Outcome of Pulmonary Resection for Pulmonary Metastases from Gastric Cancer. 胃癌肺转移肺切除术的预后结果
Go Kamimura, Masaya Aoki, Tadashi Umehara, Aya Harada-Takeda, Toshiyuki Nagata, Chihaya Koriyama, Kazuhiro Ueda

Purpose: Regardless of the devastating outcomes of pulmonary resection for metastases from gastric cancer, a handful of patients survive long after pulmonary metastasectomy. This study aimed to identify a good candidate for pulmonary resection for metastases from gastric cancer.

Methods: Between 2005 and 2023, 564 patients underwent pulmonary metastasectomy in our department, of which 12 patients underwent pulmonary resection for metastases from gastric cancer. Variables evaluated were the number and size of metastatic lesions, surgical procedure, disease-free interval (DFI), and the serum carcinoembryonic antigen at pulmonary metastasectomy.

Results: The DFI following gastrectomy ≤12.5 months group had a significantly worse overall survival (OS) than the other group (p = 0.005). A comparison between DFI following gastrectomy ≤12.5 months group and DFI following gastrectomy >12.5 months group showed a significant difference in serum carcinoembryonic antigen (CEA) value at pulmonary metastasectomy (p = 0.048). The serum CEA value at pulmonary metastasectomy >5.8 ng/ml group had a significantly worse OS than the other group (p = 0.001).

Conclusion: Pulmonary metastasectomy can be indicated in some patients with metastasis from gastric cancer who have longer DFI from gastrectomy and lower serum CEA at pulmonary metastasectomy.

目的:尽管胃癌转移肺切除术的结果令人沮丧,但仍有少数患者在肺转移切除术后长期存活。本研究旨在确定胃癌转移肺切除术的最佳候选者:2005年至2023年期间,我科共有564名患者接受了肺转移切除术,其中12名患者因胃癌转移而接受了肺切除术。评估变量包括转移病灶的数量和大小、手术方法、无病间隔期(DFI)以及肺转移切除术时的血清癌胚抗原:结果:胃切除术后 DFI≤12.5 个月组的总生存期(OS)明显低于其他组(P = 0.005)。胃切除术后 DFI ≤12.5 个月组与胃切除术后 DFI >12.5 个月组的比较显示,肺转移切除术时血清癌胚抗原(CEA)值存在显著差异(P = 0.048)。结论:肺转移灶切除术时血清癌胚抗原(CEA)值>5.8 ng/ml组的OS明显差于其他组(p = 0.001):结论:肺转移灶切除术适用于胃切除术后DFI较长、肺转移灶切除术时血清CEA较低的部分胃癌转移患者。
{"title":"Prognostic Outcome of Pulmonary Resection for Pulmonary Metastases from Gastric Cancer.","authors":"Go Kamimura, Masaya Aoki, Tadashi Umehara, Aya Harada-Takeda, Toshiyuki Nagata, Chihaya Koriyama, Kazuhiro Ueda","doi":"10.5761/atcs.oa.24-00044","DOIUrl":"10.5761/atcs.oa.24-00044","url":null,"abstract":"<p><strong>Purpose: </strong>Regardless of the devastating outcomes of pulmonary resection for metastases from gastric cancer, a handful of patients survive long after pulmonary metastasectomy. This study aimed to identify a good candidate for pulmonary resection for metastases from gastric cancer.</p><p><strong>Methods: </strong>Between 2005 and 2023, 564 patients underwent pulmonary metastasectomy in our department, of which 12 patients underwent pulmonary resection for metastases from gastric cancer. Variables evaluated were the number and size of metastatic lesions, surgical procedure, disease-free interval (DFI), and the serum carcinoembryonic antigen at pulmonary metastasectomy.</p><p><strong>Results: </strong>The DFI following gastrectomy ≤12.5 months group had a significantly worse overall survival (OS) than the other group (p = 0.005). A comparison between DFI following gastrectomy ≤12.5 months group and DFI following gastrectomy >12.5 months group showed a significant difference in serum carcinoembryonic antigen (CEA) value at pulmonary metastasectomy (p = 0.048). The serum CEA value at pulmonary metastasectomy >5.8 ng/ml group had a significantly worse OS than the other group (p = 0.001).</p><p><strong>Conclusion: </strong>Pulmonary metastasectomy can be indicated in some patients with metastasis from gastric cancer who have longer DFI from gastrectomy and lower serum CEA at pulmonary metastasectomy.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11219219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Additive Effects of Esaxerenone, a Nonsteroidal Mineralocorticoid Receptor Blocker, on Cardioplegic Arrest in Rat Hearts. 非甾体类矿物质皮质激素受体阻断剂艾沙塞龙对大鼠心脏停搏的叠加效应
Masahiro Fujii, Hiromasa Yamashita, Yasuhiro Kawase, Ryuzo Bessho, Yosuke Ishii

Purpose: Esaxerenone, a mineralocorticoid receptor blocker, attenuates global ischemia-induced myocardial damage and coronary endothelial dysfunction. This study aimed to determine whether esaxerenone exerted cardioprotective effects against cardioplegic arrest in Wistar rat hearts.

Methods: Isolated male Wistar rat hearts aerobically perfused via the Langendorff method for 20 min were randomly allocated to the Control (n = 6; perfused for an additional 10 min and subjected to no treatment) or Esax (n = 6; perfused with 0.1 μmol/L esaxerenone in perfusate for 10 min before ischemia) groups. Hearts in both groups were perfused with St. Thomas' Hospital No. 2 solution (STH2) for 2 min and subjected to 28 min of global ischemia. The recovery of left ventricular developed pressure (LVDP) and total troponin T leakage were measured after reperfusion.

Results: The final recovery of LVDP (expressed as a percentage of pre-ischemic value) in the Control and Esax groups was 50.8 ± 3.5% and 62.1 ± 5.6%, respectively (p <0.05, Esax vs. Control). The total troponin T leakage in the Control and Esax groups was 138.8 ± 18.5 ng/g heart wt and 74.3 ± 18.6 ng/g heart wt, respectively (p <0.05, Esax vs. Control).

Conclusion: The administration of esaxerenone before cardioplegic arrest enhanced the cardioprotective effect exerted by STH2.

目的:艾赛仑酮是一种矿物质皮质激素受体阻滞剂,可减轻整体缺血引起的心肌损伤和冠状动脉内皮功能障碍。本研究旨在确定埃沙塞酮是否对 Wistar 大鼠心脏的心肌梗死有保护作用:通过朗根多夫法对雄性 Wistar 大鼠心脏进行有氧灌注 20 分钟后,将其随机分配到对照组(n = 6;再灌注 10 分钟,不进行任何处理)或 Esax 组(n = 6;在缺血前灌注 10 分钟,在灌注液中加入 0.1 μmol/L 的艾塞昔酮)。两组心脏均用圣托马斯医院 2 号溶液(STH2)灌注 2 分钟,然后进行 28 分钟的全身缺血。再灌注后测量左心室显像压(LVDP)的恢复情况和肌钙蛋白T的总漏出量:在心脏麻痹停跳前给予艾司西酮能增强 STH2 的心脏保护作用。
{"title":"Additive Effects of Esaxerenone, a Nonsteroidal Mineralocorticoid Receptor Blocker, on Cardioplegic Arrest in Rat Hearts.","authors":"Masahiro Fujii, Hiromasa Yamashita, Yasuhiro Kawase, Ryuzo Bessho, Yosuke Ishii","doi":"10.5761/atcs.oa.24-00034","DOIUrl":"10.5761/atcs.oa.24-00034","url":null,"abstract":"<p><strong>Purpose: </strong>Esaxerenone, a mineralocorticoid receptor blocker, attenuates global ischemia-induced myocardial damage and coronary endothelial dysfunction. This study aimed to determine whether esaxerenone exerted cardioprotective effects against cardioplegic arrest in Wistar rat hearts.</p><p><strong>Methods: </strong>Isolated male Wistar rat hearts aerobically perfused via the Langendorff method for 20 min were randomly allocated to the Control (n = 6; perfused for an additional 10 min and subjected to no treatment) or Esax (n = 6; perfused with 0.1 μmol/L esaxerenone in perfusate for 10 min before ischemia) groups. Hearts in both groups were perfused with St. Thomas' Hospital No. 2 solution (STH2) for 2 min and subjected to 28 min of global ischemia. The recovery of left ventricular developed pressure (LVDP) and total troponin T leakage were measured after reperfusion.</p><p><strong>Results: </strong>The final recovery of LVDP (expressed as a percentage of pre-ischemic value) in the Control and Esax groups was 50.8 ± 3.5% and 62.1 ± 5.6%, respectively (p <0.05, Esax vs. Control). The total troponin T leakage in the Control and Esax groups was 138.8 ± 18.5 ng/g heart wt and 74.3 ± 18.6 ng/g heart wt, respectively (p <0.05, Esax vs. Control).</p><p><strong>Conclusion: </strong>The administration of esaxerenone before cardioplegic arrest enhanced the cardioprotective effect exerted by STH2.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141891219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Robot-Assisted Surgery for Advanced Metachronous Cancer in a Gastric Conduit after Esophagectomy: A Case Report. 机器人辅助手术成功治疗食管切除术后胃导管中的晚期转移癌:病例报告。
Kentoku Fujisawa, Masaki Ueno, Kazuya Okamoto, Hayato Shimoyama, Yu Ohkura, Shusuke Haruta, Harushi Udagawa

The incidence of gastric tube cancers has increased due to improved survival rates in patients after esophagectomy. However, the optimal surgical approach for gastric tube cancer remains controversial. Here, we report the case of a 70-year-old man with advanced gastric cancer arising from a retrosternally placed gastric conduit, 12 years after thoracic esophagectomy for esophageal cancer. Total resection of the gastric conduit was performed with robotic assistance. Although the working space was limited, secure resection was possible. Continuous en bloc mobilization was achieved with neck dissection, and reconstruction was performed via the same retrosternal route using the ileocolon. The patient was discharged on the 14th postoperative day without any adverse events. Robot-assisted surgery can overcome the technical limitations of laparoscopic mediastinal surgery and has advantages such as improved ergonomics, comfort, and elimination of hand tremors, and therefore may be an option for future minimally invasive surgeries.

由于食管切除术后患者的生存率提高,胃管癌的发病率也随之增加。然而,胃管癌的最佳手术方式仍存在争议。在此,我们报告了一例因食管癌行胸腔食管切除术 12 年后的 70 岁男性病例,该患者的晚期胃癌源于后胸腔置入的胃导管。在机器人辅助下进行了胃导管全切除术。虽然工作空间有限,但还是进行了安全的切除。通过颈部解剖实现了连续的整体移动,并通过相同的胸骨后路径使用回肠结肠进行了重建。患者于术后第14天出院,未发生任何不良反应。机器人辅助手术可以克服腹腔镜纵隔手术的技术限制,并具有改善人体工程学、舒适度和消除手颤等优点,因此可能是未来微创手术的一种选择。
{"title":"Successful Robot-Assisted Surgery for Advanced Metachronous Cancer in a Gastric Conduit after Esophagectomy: A Case Report.","authors":"Kentoku Fujisawa, Masaki Ueno, Kazuya Okamoto, Hayato Shimoyama, Yu Ohkura, Shusuke Haruta, Harushi Udagawa","doi":"10.5761/atcs.cr.23-00202","DOIUrl":"10.5761/atcs.cr.23-00202","url":null,"abstract":"<p><p>The incidence of gastric tube cancers has increased due to improved survival rates in patients after esophagectomy. However, the optimal surgical approach for gastric tube cancer remains controversial. Here, we report the case of a 70-year-old man with advanced gastric cancer arising from a retrosternally placed gastric conduit, 12 years after thoracic esophagectomy for esophageal cancer. Total resection of the gastric conduit was performed with robotic assistance. Although the working space was limited, secure resection was possible. Continuous en bloc mobilization was achieved with neck dissection, and reconstruction was performed via the same retrosternal route using the ileocolon. The patient was discharged on the 14th postoperative day without any adverse events. Robot-assisted surgery can overcome the technical limitations of laparoscopic mediastinal surgery and has advantages such as improved ergonomics, comfort, and elimination of hand tremors, and therefore may be an option for future minimally invasive surgeries.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11060837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Interval of Computed Tomography Follow-Ups after Advanced Non-Small-Cell Lung Cancer Surgery Did Not Show Any Relationship with Survival. 晚期非小细胞肺癌手术后的计算机断层扫描随访间隔与存活率无任何关系
Natsumi Maru, Haruaki Hino, Takahiro Utsumi, Hiroshi Matsui, Yohei Taniguchi, Tomohito Saito, Tomohiro Murakawa

Purpose: There is limited evidence concerning the computed tomography (CT) follow-up interval to detect recurrence and second primary cancers after surgery for non-small-cell lung cancer (NSCLC). In this study, we aimed to investigate the impact of CT interval on survival after surgery.

Methods: This retrospective study analyzed the prognosis of 103 patients who underwent periodic CT after complete resection for pathological stage II-III NSCLC at a single institute between 2015 and 2020. The patients were stratified based on the follow-up CT intervals into the half-year group (Group H) and annual group (Group A). Additionally, the underlying differences in clinical backgrounds between the 2 groups were adjusted by propensity score matching.

Results: A total of 103 patients (Group H, 76 patients; Group A, 27 patients) were included in this study. The 5-year overall survival (OS) rates in the unmatched cohort were 83.5% and 95.2% in groups H and A, respectively ( P = 0.17). Among the matched cohort, 42 and 21 patients were in groups H and A. The 5-year OS rates of the matched cohort were 89.8% and 94.4% in groups H and A ( P = 0.45), with no significant difference.

Conclusions: There was no association between CT intervals and postoperative survival.

目的:关于非小细胞肺癌(NSCLC)术后检测复发和第二原发癌的计算机断层扫描(CT)随访间隔的证据有限。在这项研究中,我们旨在调查 CT 随访间隔对术后生存的影响:这项回顾性研究分析了 2015 年至 2020 年间在一家研究所接受病理 II-III 期 NSCLC 完全切除术后定期 CT 检查的 103 例患者的预后情况。根据随访 CT 间隔时间将患者分为半年组(H 组)和一年组(A 组)。此外,还通过倾向得分匹配调整了两组之间临床背景的潜在差异:本研究共纳入 103 例患者(H 组 76 例,A 组 27 例)。H组和A组患者的5年总生存率(OS)分别为83.5%和95.2%(P = 0.17)。配对队列中,H组和A组分别有42名和21名患者。配对队列中,H组和A组的5年总生存率分别为89.8%和94.4%(P = 0.45),无显著差异:结论:CT间期与术后生存率之间没有关联。
{"title":"The Interval of Computed Tomography Follow-Ups after Advanced Non-Small-Cell Lung Cancer Surgery Did Not Show Any Relationship with Survival.","authors":"Natsumi Maru, Haruaki Hino, Takahiro Utsumi, Hiroshi Matsui, Yohei Taniguchi, Tomohito Saito, Tomohiro Murakawa","doi":"10.5761/atcs.oa.24-00093","DOIUrl":"10.5761/atcs.oa.24-00093","url":null,"abstract":"<p><strong>Purpose: </strong>There is limited evidence concerning the computed tomography (CT) follow-up interval to detect recurrence and second primary cancers after surgery for non-small-cell lung cancer (NSCLC). In this study, we aimed to investigate the impact of CT interval on survival after surgery.</p><p><strong>Methods: </strong>This retrospective study analyzed the prognosis of 103 patients who underwent periodic CT after complete resection for pathological stage II-III NSCLC at a single institute between 2015 and 2020. The patients were stratified based on the follow-up CT intervals into the half-year group (Group H) and annual group (Group A). Additionally, the underlying differences in clinical backgrounds between the 2 groups were adjusted by propensity score matching.</p><p><strong>Results: </strong>A total of 103 patients (Group H, 76 patients; Group A, 27 patients) were included in this study. The 5-year overall survival (OS) rates in the unmatched cohort were 83.5% and 95.2% in groups H and A, respectively ( P = 0.17). Among the matched cohort, 42 and 21 patients were in groups H and A. The 5-year OS rates of the matched cohort were 89.8% and 94.4% in groups H and A ( P = 0.45), with no significant difference.</p><p><strong>Conclusions: </strong>There was no association between CT intervals and postoperative survival.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11466525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dexmedetomidine Pretreatment Confers Myocardial Protection and Reduces Mechanical Ventilation Duration for Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass. 右美托咪定预处理为心肺旁路下接受心脏瓣膜置换术的患者提供心肌保护并缩短机械通气时间
Binglin Yuan, Xiqiang Huang, Junlin Wen, Mengzhe Peng

Purpose: The study aims to assess the effects of dexmedetomidine (Dex) pretreatment on patients during cardiac valve replacement under cardiopulmonary bypass.

Methods: For patients in the Dex group (n = 52), 0.5 μg/kg Dex was given before anesthesia induction, followed by 0.5 μg/kg/h pumping injection before aortic occlusion. For patients in the control group (n = 52), 0.125 ml/kg normal saline was given instead of Dex.

Results: The patients in the Dex group had longer time to first dose of rescue propofol than the control group (P = 0.003). The Dex group required less total dosage of propofol than the control group (P = 0.0001). The levels of cardiac troponin I (cTnI), creatine kinase isoenzyme MB (CK-MB), malondialdehyde (MDA), and tumor necrosis factor-α (TNF-α) were lower in the Dex group than the control group at T4, 8 h after the operation (T5), and 24 h after the operation (T6) (P <0.01). The Dex group required less time for mechanical ventilation than the control group (P = 0.003).

Conclusion: The study suggests that 0.50 µg/kg Dex pretreatment could reduce propofol use and the duration of mechanical ventilation, and confer myocardial protection without increased adverse events during cardiac valve replacement.

目的:本研究旨在评估右美托咪定(Dex)预处理对心肺旁路下心脏瓣膜置换术患者的影响:方法:对于右美托咪定组患者(n = 52),在麻醉诱导前给予 0.5 μg/kg 右美托咪定,然后在主动脉闭塞前进行 0.5 μg/kg/h 泵注。对照组患者(n = 52)使用 0.125 ml/kg 生理盐水代替地塞米松:结果:与对照组相比,地塞米松组患者首次使用抢救性异丙酚的时间更长(P = 0.003)。地塞米松组所需的异丙酚总剂量少于对照组(P = 0.0001)。在T4、术后8小时(T5)和术后24小时(T6),Dex组的心肌肌钙蛋白I(cTnI)、肌酸激酶同工酶MB(CK-MB)、丙二醛(MDA)和肿瘤坏死因子-α(TNF-α)的水平均低于对照组(P 结论:该研究表明,0.50微克的Dex能显著降低心肌肌钙蛋白I(cTnI)、肌酸激酶同工酶MB(CK-MB)、丙二醛(MDA)和肿瘤坏死因子-α(TNF-α)的水平:该研究表明,0.50 µg/kg Dex 预处理可减少异丙酚的使用和机械通气的持续时间,并在不增加心脏瓣膜置换术不良事件的情况下提供心肌保护。
{"title":"Dexmedetomidine Pretreatment Confers Myocardial Protection and Reduces Mechanical Ventilation Duration for Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass.","authors":"Binglin Yuan, Xiqiang Huang, Junlin Wen, Mengzhe Peng","doi":"10.5761/atcs.oa.23-00210","DOIUrl":"10.5761/atcs.oa.23-00210","url":null,"abstract":"<p><strong>Purpose: </strong>The study aims to assess the effects of dexmedetomidine (Dex) pretreatment on patients during cardiac valve replacement under cardiopulmonary bypass.</p><p><strong>Methods: </strong>For patients in the Dex group (n = 52), 0.5 μg/kg Dex was given before anesthesia induction, followed by 0.5 μg/kg/h pumping injection before aortic occlusion. For patients in the control group (n = 52), 0.125 ml/kg normal saline was given instead of Dex.</p><p><strong>Results: </strong>The patients in the Dex group had longer time to first dose of rescue propofol than the control group (P = 0.003). The Dex group required less total dosage of propofol than the control group (P = 0.0001). The levels of cardiac troponin I (cTnI), creatine kinase isoenzyme MB (CK-MB), malondialdehyde (MDA), and tumor necrosis factor-α (TNF-α) were lower in the Dex group than the control group at T4, 8 h after the operation (T5), and 24 h after the operation (T6) (P <0.01). The Dex group required less time for mechanical ventilation than the control group (P = 0.003).</p><p><strong>Conclusion: </strong>The study suggests that 0.50 µg/kg Dex pretreatment could reduce propofol use and the duration of mechanical ventilation, and confer myocardial protection without increased adverse events during cardiac valve replacement.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082494/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Incidentally Discovered Congenital Complete Pericardial Defect during Lobectomy for Lung Cancer: A Case Report and Literature Review. 一例肺癌肺叶切除术中意外发现的先天性完全心包缺损:病例报告与文献综述
Tomohiro Setogawa, Taketo Kato, Hiroki Watanabe, Shota Nakamura, Tetsuya Mizuno, Toyofumi Fengshi Chen-Yoshikawa

An 82-year-old male patient underwent a left upper lobectomy with anterolateral thoracotomy for lung cancer. Although a complete left-pericardial defect was observed during surgery, the pericardial repair was not performed because the left lower lobe remained and the heart was considered stable. Postoperative pathological examination revealed primary synchronous double-lung squamous-cell carcinoma (pathological stage pT2a(2)N0M0 stage IB). He was discharged without complications on postoperative day 8. Leftward displacement of the heart and left diaphragmatic elevation, suspected of phrenic-nerve paralysis, were found in the chest X-ray after discharge. However, the patient's overall condition remained unaffected at the 5-month postoperative follow-up. To assess the need for pericardial repair, we compared cases of complete pericardial defects observed during lobectomy or pneumonectomy reported in the literature. Only one of 12 cases occurred postoperative death despite pericardial repair, and that case combined pectus excavatum and pericardial defects. Our assessment indicated that pericardial repair might not be necessary, excluding complex cases.

一名 82 岁的男性患者因患肺癌接受了左上肺叶切除术和前外侧开胸手术。虽然手术中观察到左心包完全缺损,但由于左肺下叶仍然存在,且心脏情况稳定,因此没有进行心包修补。术后病理检查发现原发性同步双肺鳞癌(病理分期 pT2a(2)N0M0 IB 期)。术后第 8 天,患者无并发症出院。出院后胸部 X 光检查发现心脏向左移位,左侧膈肌抬高,疑为膈神经麻痹。不过,术后 5 个月随访时,患者的整体状况未受影响。为了评估心包修补的必要性,我们比较了文献中报道的在肺叶切除术或肺切除术中观察到的完全心包缺损病例。在12例病例中,只有一例尽管进行了心包修补术,但仍在术后死亡,该病例同时合并了心胸和心包缺损。我们的评估结果表明,除复杂病例外,可能没有必要进行心包修补。
{"title":"A Case of Incidentally Discovered Congenital Complete Pericardial Defect during Lobectomy for Lung Cancer: A Case Report and Literature Review.","authors":"Tomohiro Setogawa, Taketo Kato, Hiroki Watanabe, Shota Nakamura, Tetsuya Mizuno, Toyofumi Fengshi Chen-Yoshikawa","doi":"10.5761/atcs.cr.24-00041","DOIUrl":"10.5761/atcs.cr.24-00041","url":null,"abstract":"<p><p>An 82-year-old male patient underwent a left upper lobectomy with anterolateral thoracotomy for lung cancer. Although a complete left-pericardial defect was observed during surgery, the pericardial repair was not performed because the left lower lobe remained and the heart was considered stable. Postoperative pathological examination revealed primary synchronous double-lung squamous-cell carcinoma (pathological stage pT2a(2)N0M0 stage IB). He was discharged without complications on postoperative day 8. Leftward displacement of the heart and left diaphragmatic elevation, suspected of phrenic-nerve paralysis, were found in the chest X-ray after discharge. However, the patient's overall condition remained unaffected at the 5-month postoperative follow-up. To assess the need for pericardial repair, we compared cases of complete pericardial defects observed during lobectomy or pneumonectomy reported in the literature. Only one of 12 cases occurred postoperative death despite pericardial repair, and that case combined pectus excavatum and pericardial defects. Our assessment indicated that pericardial repair might not be necessary, excluding complex cases.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140944245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcome of the Type A Acute Aortic Dissection Repair Using the "Tailored Stand-Up Collar" Technique. 使用 "量身定制的站立领 "技术进行 A 型急性主动脉夹层修复术的临床效果。
Yukio Umeda, Yuta Inoue, Shohei Mitta, Yukihiro Matsuno, Shoji Yoshikawa

Purpose: Achieving a secure anastomosis and complete hemostasis is essential for surgically treating type A acute aortic dissection (TAAAD). This study assessed the clinical feasibility of "tailored stand-up collar (TSC)" technique for constructing the distal stump.

Methods: We enrolled 68 patients who underwent ascending aortic repair for TAAAD. Patients were categorized according to the technique for distal stump construction: conventional (C) group using only a felt strip (32 cases); post-aortotomy (P) group, with a Hydrofit-felt strip attached after aortotomy (18 cases), and TSC group, where a Hydrofit-felt strip attached during cooling (18 cases). Pre-operative characteristics, procedural profiles, and post-operative outcomes were evaluated.

Results: The pre-operative characteristics were identical among the groups. The durations of cardiopulmonary bypass, hemostasis, and surgery were significantly shorter in the P and TSC groups. The duration of open distal in the TSC group (21 min) was significantly shorter than the other two groups. Post-operative additional procedures were not required for the TSC group and their post-operative hospital stay was significantly shorter (47.1% of patients were discharged within 2 weeks).

Conclusion: The TSC technique would be practical because of its high reproducibility in terms of ease of use, shorter anastomotic time, and secure hemostasis.

目的:实现安全吻合和完全止血是手术治疗A型急性主动脉夹层(TAAAD)的关键。本研究评估了 "量身定制的立领(TSC)"技术在构建远端残端方面的临床可行性:我们招募了 68 名因 TAAAD 而接受升主动脉修补术的患者。根据远端残端构建技术对患者进行分类:传统(C)组,仅使用毡条(32 例);主动脉切开术后(P)组,在主动脉切开术后粘贴 Hydrofit 毡条(18 例);TSC 组,在冷却过程中粘贴 Hydrofit 毡条(18 例)。对术前特征、手术概况和术后结果进行了评估:各组的术前特征相同。P组和TSC组的心肺旁路、止血和手术时间明显更短。TSC 组的远端开放时间(21 分钟)明显短于其他两组。TSC 组患者术后无需进行额外的手术,其术后住院时间也明显缩短(47.1% 的患者在 2 周内出院):结论:TSC 技术具有高度的可重复性,使用方便,吻合时间短,止血安全,因此非常实用。
{"title":"Clinical Outcome of the Type A Acute Aortic Dissection Repair Using the \"Tailored Stand-Up Collar\" Technique.","authors":"Yukio Umeda, Yuta Inoue, Shohei Mitta, Yukihiro Matsuno, Shoji Yoshikawa","doi":"10.5761/atcs.oa.23-00214","DOIUrl":"10.5761/atcs.oa.23-00214","url":null,"abstract":"<p><strong>Purpose: </strong>Achieving a secure anastomosis and complete hemostasis is essential for surgically treating type A acute aortic dissection (TAAAD). This study assessed the clinical feasibility of \"tailored stand-up collar (TSC)\" technique for constructing the distal stump.</p><p><strong>Methods: </strong>We enrolled 68 patients who underwent ascending aortic repair for TAAAD. Patients were categorized according to the technique for distal stump construction: conventional (C) group using only a felt strip (32 cases); post-aortotomy (P) group, with a Hydrofit-felt strip attached after aortotomy (18 cases), and TSC group, where a Hydrofit-felt strip attached during cooling (18 cases). Pre-operative characteristics, procedural profiles, and post-operative outcomes were evaluated.</p><p><strong>Results: </strong>The pre-operative characteristics were identical among the groups. The durations of cardiopulmonary bypass, hemostasis, and surgery were significantly shorter in the P and TSC groups. The duration of open distal in the TSC group (21 min) was significantly shorter than the other two groups. Post-operative additional procedures were not required for the TSC group and their post-operative hospital stay was significantly shorter (47.1% of patients were discharged within 2 weeks).</p><p><strong>Conclusion: </strong>The TSC technique would be practical because of its high reproducibility in terms of ease of use, shorter anastomotic time, and secure hemostasis.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140944303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Outcomes of Coronary Artery Bypass Grafting Using an Internal Thoracic Artery versus a Radial Artery as a Second Arterial Graft. 使用胸内动脉与桡动脉作为第二动脉移植的冠状动脉旁路移植术的长期疗效。
Ryoma Oda, Kan Kajimoto, Taira Yamamoto, Daisuke Endo, Takeshi Kinoshita, Atsushi Amano, Minoru Tabata

Purpose: To compare the outcomes of left circumflex artery (LCx) revascularization using an internal thoracic artery (ITA) or radial artery (RA) as the second arterial graft.

Methods: Patients who underwent primary isolated coronary artery bypass grafting with left anterior descending artery revascularization using an ITA and LCx revascularization using another bilateral ITA (BITA group) or an RA (ITA-RA group) were included. All-cause mortality (primary endpoint), cardiac death, major adverse cardiac events, in-hospital death, and deep sternal wound infection (secondary endpoints) were evaluated.

Results: Among 790 patients (BITA, n = 548 (69%); ITA-RA, n = 242 (31%)), no significant difference in all-cause mortality between the groups was observed (hazard ratio (HR): 0.87; 95% confidence interval (CI): 0.67-1.12; p = 0.27) during follow-up (mean, 10 years). Multivariate analysis revealed that the BITA group exhibited significantly lower rates of long-term all-cause mortality (HR: 0.63; 95% CI: 0.48-0.84; p = 0.01). In the propensity-matched cohort (n = 480, 240 pairs), significantly fewer all-cause deaths occurred in the BITA group (HR: 0.66; 95% CI 0.47-0.93; p = 0.02). There were no significant differences in secondary outcomes.

Conclusions: When used as second grafts for LCx revascularization, ITA grafts may surpass RA grafts in reducing all-cause mortality 10 years postoperatively.

目的:比较使用胸内动脉(ITA)或桡动脉(RA)作为第二动脉移植物进行左侧环状动脉(LCx)再血管化的疗效:方法:纳入接受初级孤立冠状动脉旁路移植术的患者,使用ITA进行左前降支动脉再血管化,并使用另一条双侧ITA(BITA组)或RA(ITA-RA组)进行LCx再血管化。对全因死亡率(主要终点)、心源性死亡、主要不良心脏事件、院内死亡和胸骨深部伤口感染(次要终点)进行了评估:在790名患者中(BITA,n = 548 (69%);ITA-RA,n = 242 (31%)),随访期间(平均10年)未观察到组间全因死亡率的显著差异(危险比(HR):0.87;95%置信区间(CI):0.67-1.12;P = 0.27)。多变量分析显示,BITA 组的长期全因死亡率明显较低(HR:0.63;95% CI:0.48-0.84;P = 0.01)。在倾向匹配队列(n = 480,240 对)中,BITA 组的全因死亡率明显较低(HR:0.66;95% CI 0.47-0.93;p = 0.02)。次要结果无明显差异:结论:ITA移植物作为LCx血管再通的第二种移植物时,在降低术后10年全因死亡率方面可能超过RA移植物。
{"title":"Long-Term Outcomes of Coronary Artery Bypass Grafting Using an Internal Thoracic Artery versus a Radial Artery as a Second Arterial Graft.","authors":"Ryoma Oda, Kan Kajimoto, Taira Yamamoto, Daisuke Endo, Takeshi Kinoshita, Atsushi Amano, Minoru Tabata","doi":"10.5761/atcs.oa.24-00029","DOIUrl":"10.5761/atcs.oa.24-00029","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the outcomes of left circumflex artery (LCx) revascularization using an internal thoracic artery (ITA) or radial artery (RA) as the second arterial graft.</p><p><strong>Methods: </strong>Patients who underwent primary isolated coronary artery bypass grafting with left anterior descending artery revascularization using an ITA and LCx revascularization using another bilateral ITA (BITA group) or an RA (ITA-RA group) were included. All-cause mortality (primary endpoint), cardiac death, major adverse cardiac events, in-hospital death, and deep sternal wound infection (secondary endpoints) were evaluated.</p><p><strong>Results: </strong>Among 790 patients (BITA, n = 548 (69%); ITA-RA, n = 242 (31%)), no significant difference in all-cause mortality between the groups was observed (hazard ratio (HR): 0.87; 95% confidence interval (CI): 0.67-1.12; p = 0.27) during follow-up (mean, 10 years). Multivariate analysis revealed that the BITA group exhibited significantly lower rates of long-term all-cause mortality (HR: 0.63; 95% CI: 0.48-0.84; p = 0.01). In the propensity-matched cohort (n = 480, 240 pairs), significantly fewer all-cause deaths occurred in the BITA group (HR: 0.66; 95% CI 0.47-0.93; p = 0.02). There were no significant differences in secondary outcomes.</p><p><strong>Conclusions: </strong>When used as second grafts for LCx revascularization, ITA grafts may surpass RA grafts in reducing all-cause mortality 10 years postoperatively.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrathoracic Needle Migration from the Mediastinum into the Thoracic Cavity. 胸腔内针头从纵隔移入胸腔。
Tomo Sato, Yasufumi Kato, Hiroaki Kataba, Koichi Yoshida, Hiroki Hayashi, Masatoshi Kakihana, Norihiko Ikeda

Intrathoracic needles are rarely used in clinical practice. They can migrate within the body, injure large blood vessels and other organs, and cause severe complications. We report an interesting case of intrathoracic needle removal using video-assisted thoracoscopic surgery. The needle was inserted under the left clavicle, penetrated the mediastinum, and migrated into the right thoracic cavity. Although pneumothorax developed during the disease course, no severe complications were observed. This rare case illustrates the course of needle migration from the mediastinum into the thoracic cavity. Prompt imaging and surgical removal of foreign bodies are necessary in cases of intrathoracic foreign bodies.

临床上很少使用胸腔内针。它们可能会在体内移位,伤及大血管和其他器官,并引起严重的并发症。我们报告了一例利用视频辅助胸腔镜手术取出胸腔内针的有趣病例。针头从左锁骨下插入,穿透纵隔,移入右胸腔。虽然在病程中出现了气胸,但没有观察到严重的并发症。这一罕见病例说明了针头从纵隔移入胸腔的过程。对于胸腔内异物病例,有必要及时进行影像学检查和手术取出异物。
{"title":"Intrathoracic Needle Migration from the Mediastinum into the Thoracic Cavity.","authors":"Tomo Sato, Yasufumi Kato, Hiroaki Kataba, Koichi Yoshida, Hiroki Hayashi, Masatoshi Kakihana, Norihiko Ikeda","doi":"10.5761/atcs.cr.24-00039","DOIUrl":"10.5761/atcs.cr.24-00039","url":null,"abstract":"<p><p>Intrathoracic needles are rarely used in clinical practice. They can migrate within the body, injure large blood vessels and other organs, and cause severe complications. We report an interesting case of intrathoracic needle removal using video-assisted thoracoscopic surgery. The needle was inserted under the left clavicle, penetrated the mediastinum, and migrated into the right thoracic cavity. Although pneumothorax developed during the disease course, no severe complications were observed. This rare case illustrates the course of needle migration from the mediastinum into the thoracic cavity. Prompt imaging and surgical removal of foreign bodies are necessary in cases of intrathoracic foreign bodies.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical and Perioperative Treatments for Esophagogastric Junction Cancer. 食管胃交界癌的手术和围手术期治疗。
Yoshitomo Yanagimoto, Yukinori Kurokawa, Yuichiro Doki

Esophagogastric junction cancer (EGJC) is a rare malignant disease that occurs in the gastroesophageal transition zone. In recent years, its incidence has been rapidly increasing not only in Western countries but also in East Asia, and it has been attracting the attention of both clinicians and researchers. EGJC has a worse prognosis than gastric cancer (GC) and is characterized by complex lymphatic drainage pathways in the mediastinal and abdominal regions. EGJC was previously treated in the same way as GC or esophageal cancer, but, in recent years, it has been treated as an independent malignant disease, and treatment focusing only on EGJC has been developed. A recent multicenter prospective study revealed the frequency of lymph node metastasis by station and established the optimal extent of lymph node dissection. In perioperative treatment, the combination of multi-drug chemotherapy, radiation therapy, molecular targeted therapy, and immunotherapy is expected to improve the prognosis. In this review, we summarize previous clinical trials and their important evidence on surgical and perioperative treatments for EGJC.

食管胃交界癌(EGJC)是一种发生在胃食管过渡区的罕见恶性疾病。近年来,其发病率不仅在西方国家迅速上升,在东亚地区也同样如此,并引起了临床医生和研究人员的关注。与胃癌(GC)相比,EGJC 的预后更差,其特点是纵隔和腹腔淋巴引流路径复杂。以前,EGJC 的治疗方法与胃癌或食管癌相同,但近年来,EGJC 已被作为一种独立的恶性疾病来治疗,并发展出只针对 EGJC 的治疗方法。最近的一项多中心前瞻性研究显示了各站淋巴结转移的频率,并确定了淋巴结清扫的最佳范围。在围手术期治疗中,多种药物化疗、放射治疗、分子靶向治疗和免疫治疗的联合应用有望改善预后。在这篇综述中,我们总结了以往的临床试验及其对 EGJC 手术和围手术期治疗的重要证据。
{"title":"Surgical and Perioperative Treatments for Esophagogastric Junction Cancer.","authors":"Yoshitomo Yanagimoto, Yukinori Kurokawa, Yuichiro Doki","doi":"10.5761/atcs.ra.24-00056","DOIUrl":"10.5761/atcs.ra.24-00056","url":null,"abstract":"<p><p>Esophagogastric junction cancer (EGJC) is a rare malignant disease that occurs in the gastroesophageal transition zone. In recent years, its incidence has been rapidly increasing not only in Western countries but also in East Asia, and it has been attracting the attention of both clinicians and researchers. EGJC has a worse prognosis than gastric cancer (GC) and is characterized by complex lymphatic drainage pathways in the mediastinal and abdominal regions. EGJC was previously treated in the same way as GC or esophageal cancer, but, in recent years, it has been treated as an independent malignant disease, and treatment focusing only on EGJC has been developed. A recent multicenter prospective study revealed the frequency of lymph node metastasis by station and established the optimal extent of lymph node dissection. In perioperative treatment, the combination of multi-drug chemotherapy, radiation therapy, molecular targeted therapy, and immunotherapy is expected to improve the prognosis. In this review, we summarize previous clinical trials and their important evidence on surgical and perioperative treatments for EGJC.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141262321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1